Predicting Alzheimer's disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling
Alzheimer's & Dementia · 2025-01 · 21 (1)
DOI: 10.1002/alz.14241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 15.01.2025. Verfasst von Xiaoqing Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics & Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Transcriptome, Gene Expression Profiling. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Indiana University Precision Health Initiative NIH TREAT-AD U54, Alzheimer's Disease Neuroimaging Initiative, NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Deciphering the diverse molecular mechanisms in living Alzheimer's disease (AD) patients is a big challenge but is pivotal for disease prognosis and precision medicine development. METHODS Utilizing an optimal transport approach, we conducted graph‐based mapping of transcriptomic profiles to transfer AD subtype labels from ROSMAP monocyte samples to ADNI and ANMerge peripheral blood mononuclear cells. Subsequently, differential expression followed by comparative pathway and diffusion pseudotime analysis were applied to each cohort to infer the progression trajectories. Survival analysis with real follow‐up time was used to obtain potential biomarkers for AD prognosis. RESULTS AD subtype labels were accurately transferred onto the blood samples of ADNI and ANMerge living patients. Pathways and associated genes in neutrophil degranulation‐like immune process, immune acute phase response, and IL‐6 signaling were significantly associated with AD progression. DISCUSSION The work enhanced our understanding of AD progression in different subtypes, offering insights into potential biomarkers and personalized interventions for improved patient care. Highlights We applied an innovative optimal transport‐based approach to map transcriptomic data from different Alzheimer's disease (AD) cohort studies and transfer known AD subtype labels from ROSMAP monocyte samples to peripheral blood mononuclear cell (PBMC) samples within ADNI and ANMerge cohorts. Through comprehensive trajectory and comparative analysis, we investigated the molecular mechanisms underlying different disease progression trajectories in AD. We validated the accuracy of our AD subtype label transfer and identified prognostic genetic markers associated with disease progression, facilitating personalized treatment strategies. By identifying and predicting distinctive AD subtypes and their associated pathways, our study contributes to a deeper understanding of AD heterogeneity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics & Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Biohealth Informatics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Medical & Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
ORCID-Profile: Xiaoqing Huang
Förderung
- Indiana University Precision Health Initiative NIH TREAT-AD U54
- Alzheimer's Disease Neuroimaging Initiative
- NIA NIH HHS
- Alzheimer's Drug Discovery Foundation
- Alzheimer's Association
- AbbVie
- F. Hoffmann-La Roche Ltd
- Elan Pharmaceuticals, Inc.
Zitieren
APA
Huang, X., Jannu, A. J., Song, Z., Jury-Garfe, N., Lasagna-Reeves, C. A., Alzheimer's Disease Neuroimaging Initiative, Johnson, T. S., Huang, K., & Zhang, J. (2025). Predicting Alzheimer's disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling. Alzheimer's & Dementia, 21(1). https://doi.org/10.1002/alz.14241
Vancouver
Huang X, Jannu AJ, Song Z, Jury-Garfe N, Lasagna-Reeves CA, Alzheimer's Disease Neuroimaging Initiative, et al. Predicting Alzheimer's disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling. Alzheimer's & Dementia. 2025;21(1). doi:10.1002/alz.14241
BibTeX
@article{Huang2025,
author = {Huang, Xiaoqing and Jannu, Asha Jacob and Song, Ziyan and Jury-Garfe, Nur and Lasagna-Reeves, Cristian A and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative and Johnson, Travis S and Huang, Kun and Zhang, Jie},
title = {Predicting Alzheimer's disease subtypes and understanding their molecular characteristics in living patients with transcriptomic trajectory profiling},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {1},
doi = {10.1002/alz.14241}
}
EUVIMED